Honeywell announces new appointments
Names Jim Bujold as President, SE Asia and Anant Maheshwari as President, Honeywell India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
Quintiles launches Data-driven Trial Execution
New offering improves the quality and predictability of clinical development while reducing overall trial costs by up to 25 per…
Patient safety highlighted in quality standards for labelling of ferrules and cap overseals
The standard indicates that ferrules and cap overseals must remain clear of any markings, including logos, except those intended…
ONFAB announces joint venture with Schematic Engineering Industries
To effectively apply flexible containment as a technology for pharmaceutical companies
In-Sight Track & Trace Systems by Cognex
In-Sight Track & Trace is powered to create a complete identification and data verification solution for labels on…
Bone Therapeutics initiates a phase IIb/III trial
Receives approval from Competent Authorities in Belgium, France and the Netherlands
New human peptide may help treat diabetes
A humanin analogue increaed insulin secretion leading to an increase in glucose metabolism within beta cells
Redefining CSR
Companies Bill 2012’s two per cent mandate for CSR has evoked mixed reviews from the pharma industry. Some have welcomed the move,…
It is high time that CCI takes steps to curb anti-competitive settlements
MM Sharma, Head-Competition Law and Policy, Vaish Associates Advocates speaks to Usha Sharma about the strategy
Bribery and corruption in public procurement in India: A unique approach
Arpinder Singh, Partner & National Leader – Fraud Investigation and Dispute Services, EY (India) and Rajiv Joshi, Director –…
’India will become free from NTDs by 2020’
India is in a position to elevate Neglected Tropical Diseases (NTDs) and build awareness on how their control and elimination will…
Strides Arcolab completes sale of Agila Specialties division to Mylan
$250 million to be payable upon satisfaction of certain regulatory conditions
UK partners with BioAsia as principal country partner
Partners with BioAsia as principal country partner
Jubilant Life Sciences receives ANDA approval for Quetiapine Fumarate tablets
Is indicated for the treatment of schizophrenia, and for the treatment of acute manic episodes associated with bipolar disorder
Venus Remedies signs MoU for Elores with South African pharmaceutical firm
Expects to generate a cumulative revenue of $20 million within five years of the launch
EMA approves new tuberculosis drug delamanid
Otsuka’s phase III clinical trials for delamanid are now underway
Lilly enters branded generics market with launch of Lil Therapeutics
Announces launch of drugs in breast cancer and colo-rectal cancer segment
Cadila Pharmaceuticals and UK’s Helperby Therapeutics in pact
Helperby will supply Cadila Pharmaceuticals with antibiotic resistance breakers
… launches ’Mycidac-C’
The drug is a first in the class active immunotherapy as well as drug targeting Desmocollin-3